Suzhou, China

Zihao Dai

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Precigenome, LLC, Suzhou Precigenome Ltd. Co.. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Zihao Dai

Introduction

Zihao Dai is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of microfluidics and nanoparticle synthesis. His innovative work has led to the development of advanced systems that enhance the efficiency and accuracy of nanoparticle production.

Latest Patents

Zihao Dai holds a patent for a "Microfluidics-based nanoparticle synthesis system, and device and method using same." This system comprises a microfluidic chip, a reagent bottle connected to the chip, and a flow control assembly featuring a pressure controller. The design allows for high-accuracy flow control and rapid mixing, resulting in high-throughput and uniform nanoparticle synthesis. Users can adjust the instrument to achieve different throughputs without the need for redesign.

Career Highlights

Throughout his career, Zihao Dai has worked with notable companies such as Precigenome, LLC and Suzhou Precigenome Ltd. Co. His experience in these organizations has contributed to his expertise in the field of nanoparticle synthesis and microfluidics.

Collaborations

Zihao Dai has collaborated with talented individuals in his field, including Yaqi Wang and Yunfeng Ling. These collaborations have further enriched his research and development efforts.

Conclusion

Zihao Dai's innovative contributions to microfluidics and nanoparticle synthesis demonstrate his commitment to advancing technology in this area. His patent and career achievements reflect his significant impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…